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In the past half century, bacterial vaginosis (BV) has been a controversial topic in medical microbiology, and 
despite the wealth of information on this topic, the etiological agent has not yet been definitively identified [1]. 
The first advances on BV pointed Gardnerella vaginalis as the infectious causative agent of BV [2] but soon 
after it was found that G. vaginalis was also present in healthy women [3]. Additionally, G. vaginalis was not 
able to cause BV consistently. Furthermore, other microorganisms started to be associated with BV, and this 
resulted in a shift in the paradigm to that of a multispecies infection. However, epidemiological data revealed 
inconsistencies with this latter theory [4]. A couple of years ago the first descriptions of multispecies biofilm 
communities were described in BV [5]. Interestingly, G. vaginalis was present in most cases and accounted for 
the majority of the biofilm biomass. Further studies demonstrated that biofilm-forming G. vaginalis presented 
higher tolerance to external stresses [6].  
Taking these data into consideration, we hypothesized that strains of G. vaginalis that were able to form biofilms 
could be the causative agent of BV. To test our hypothesis, we isolated more than 30 bacterial species from BV 
patients and also several strains of G. vaginalis from healthy women, and tested biofilm forming ability, initial 
adhesion to human vaginal cells, cytotoxicity activity, antimicrobial resistance and gene expression of know 
virulent genes.  
Our results revealed that G. vaginalis outcompeted all the other bacterial species in the initial adhesion to the 
epithelial cells. Furthermore, when comparing BV-associated G. vaginalis strains to strains isolated from healthy 
women, we found that all 7strains from BV were more virulent than the 7 strains colonizing healthy women, as 
measured by the higher cytotoxicity and the higher initial adhesion to epithelial cells. No significant differences 
were found in antimicrobial resistance profiles. Interestingly, no significant differences in expression of known 
virulence genes were detected, suggesting that the higher virulence of the BV-associated G. vaginalis was due to 
a yet unknown virulence determinant. We then tested virulent G. vaginalis against other known BV-associated 
anaerobe pathogens, namely Mobiluncus mulieris, Atopobium vaginae, Prevotella bivia and Fusobacteria 
nucleatum in mixed biofilm formation quantification. Interestingly, while the other tested anaerobes did not 
reveal a higher initial adhesion, they did enhance biofilm formation by G. vaginalis. 
Overall, our data suggests that virulent variants of G. vaginalis have the potential to be the etiological agent of 
BV, while acknowledging that other anaerobes do enhance G. vaginalis virulence.  
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Gallic acid (GA), or 3,4,5-trihydroxybenzoic acid, is the commonest and simplest phenolic acid, with just one 
aromatic ring. This phenolic molecule has been described as antioxidant, anti-inflammatory and anti-tumour, 
also, antimicrobial and anti-fungal activity has been attributed to it. Besides all the GA biological activities, this 
compound is cheap, due to the easy plant extraction, and non-toxic. Thus, this phenolic acid has been widely 
used in food, drugs and cosmetic industry.  
GA, as other phenolic compounds, is susceptible to environmental factors which may lead to the losing their 
structural integrity and bioactivity. This can be overcome by the encapsulation with cyclodextrins (CD). They are 
cyclic oligosaccharides arising from the degradation of starch; inexpensive and friendly to humans. CD are able 
to form an inclusion complex with a wide range of bioactive molecules, including hydrophobic ones, protect and 
modulate their release. 
In the present work, the formation of an inclusion complex (IC) between CD, HPCD (2-Hydroxypropyl--
cyclodextrin) or MCD (methyl--cyclodextrin) and GA was analysed by UV spectrophotometry. The 
antimicrobial activity of the complexes was also assessed, by qualitative and quantitative methods. The influence 
of the buffer and pH on the formation of the IC and on the GA antimicrobial activity was also tested. 
The IC formation was analysed in 2 buffer solutions (K2HPO4/ KH2PO4 and H3PO4/NaOH). The GA and IC 
absorbance spectrum showed different appearances depending on the buffer used. When K2HPO4/ KH2PO4 was 
used, the IC spectrum presented some alterations on the max comparatively to the GA spectrum. Since, the GA 
and ICs spectra obtained for the H3PO4/NaOH were similar, this buffer was selected. 
The IC formation between GA and CD, HPCD or MCD was analysed at pH 5, 7 and 8. Based on the results it 
was clear that the pH used affected the IC formation in the conditions tested. The CD formed IC 1:1 with GA 
for all pH values, being the pH5 the most favourable. The same was observed for MCD, but these CD had the 
lowest values for the association constant, meaning that the IC formation between MCD and GA is not very 
efficient. Regarding the HPCD, in neutral pH the IC formed was 1:2 and for the others pH was 1:1, pH5 was the 
most favourable for the IC formation and pH7 the least. 
The antimicrobial activity was assessed for the best combinations of GA/CD (CD pH5 and pH7; HPCD pH5 
and pH8). For all the IC tested, the antimicrobial activity of GA was improved or alike to the GA without 
encapsulation. To the authors knowledge, the IC formation between HPCD or MCD and GA has not been 
reported until know, as well as the antimicrobial activity of the IC CD/GA and HPCD/GA. 
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